U.S. FDA Approves Kaléo's AUVI-Q(R) (Epinephrine Injection, USP) 0.1 mg Auto-Injector for Life-Threatening Allergic Reactions in Infants and Small Children

First and only epinephrine auto-injector (EAI) approved with a needle length and dose specifically designed for infants and children weighing 16.5 to 33 pounds (7.5 to 15 kilograms) Anaphylaxis and food allergies increasing in children; previously no EA... Biopharmaceuticals, Devices, Drug Delivery, FDA Kaléo, AUVI-Q, Epinephrine, auto-injector
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news